TABLE 6.

Estimated survival rates at four years, according to stratification variables

Variable	4-yr recurrence- free survival (%, 95% CI)	4-yr cancer-related survival (%, 95% CI)	4-yr overall survival (%, 95% CI)
Body Mass Index < 30
Lymph Nodes Sampled (n=199)
Pelvic Radiation	71 (61–81)	86 (78–94)	76 (66–86)
No Pelvic Radiation	82 (74–90)	89 (81–97)	83 (74–92)
p-value	0.07	0.28	0.11
Lymph Nodes NOT Sampled (n=188)
Pelvic Radiation	65 (52–78)	90 (64–92)	78 (65–91)
No Pelvic Radiation	84 (76–92)	98 (95–100)	88 (82–94)
p-value	0.04	<0.001	0.08
Body Mass Index ≥ 30
Lymph Nodes Sampled (n=179)
Pelvic Radiation	67 (54–80)	80 (69–91)	69 (56–82)
No Pelvic Radiation	86 (78–94)	94 (88–100)	86 (78–94)
p-value	0.01	0.01	0.004
Lymph Nodes NOT Sampled (n=200)
Pelvic Radiation	78 (66–90)	90 (82–100)	74 (61–87)
No Pelvic Radiation	89 (81–97)	99 (97–100)	93 (87–99)
p-value	0.03	0.01	<0.001

Kaplan Meier survival analysis